Bio-Techne (TECH) Total Debt (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.08% |
| Dec 31, 2025 | -13.33% |
| Sep 30, 2025 | -13.29% |
| Jun 30, 2025 | 4.85% |
| Mar 31, 2025 | 10.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -5.96% |
| Jun 30, 2024 | -17.99% |
| Mar 31, 2024 | -12.98% |
| Dec 31, 2023 | 1.19% |
| Sep 30, 2023 | 24.96% |
| Jun 30, 2023 | -5.80% |
| Mar 31, 2023 | 87.63% |
| Dec 31, 2022 | -26.49% |
| Sep 30, 2022 | 6.31% |
| Jun 30, 2022 | -1.20% |
| Mar 31, 2022 | -4.64% |
| Dec 31, 2021 | -7.21% |
| Sep 30, 2021 | -14.24% |
| Jun 30, 2021 | 64.10% |
| Mar 31, 2021 | -7.15% |
| Dec 31, 2020 | -29.32% |
| Sep 30, 2020 | -11.16% |
| Jun 30, 2020 | -13.73% |
| Mar 31, 2020 | 7.98% |
| Dec 31, 2019 | -21.21% |
| Sep 30, 2019 | -3.78% |
| Jun 30, 2019 | -3.28% |
| Mar 31, 2019 | -4.24% |
| Dec 31, 2018 | -2.87% |
| Sep 30, 2018 | 65.63% |
| Jun 30, 2018 | -14.39% |
| Mar 31, 2018 | -4.76% |
| Dec 31, 2017 | 9.88% |
| Sep 30, 2017 | -7.45% |
| Jun 30, 2017 | -0.50% |
| Mar 31, 2017 | 0.92% |
| Dec 31, 2016 | 3.50% |
| Sep 30, 2016 | 329.95% |
| Jun 30, 2016 | -42.02% |
| Mar 31, 2016 | -3.06% |
| Dec 31, 2015 | -0.96% |
| Sep 30, 2015 | 125.16% |
| Jun 30, 2015 | 811.25% |
| Mar 31, 2015 | -94.44% |
| Dec 31, 2014 | 28.57% |
| Sep 30, 2014 | 1,500.69% |